Table 1.

Selected series of SBRT for early stage HCC

Author, year [reference]	Patient number	Tumor size (cm)*	RT dose (Gy)	Number of fractions	Median follow-up (months)	1-Y OS	3-Y OS	≥ G3 hepatic toxicity
Sanuki, 2013 [8]	185	2.5; 0.8–5	40	5	24	95%	70%	13%
Yoon, 2013 [9]	93	2; 1–6	30–40	3–4	25.6	86%	54%	6.5%
Kwon, 2010 [10]	42	15.4; 3–81.8	30–39	3	28.7	92%	58%	0%

Y=year.

^*Values are the median and range.